Tesla Korea has come under criticism for its poor after-sales service system and infrastructure, as the carmaker reportedly ...
MiniZ Electric Loader The MiniZ delivers performance that rivals its internal combustion counterparts thanks to the robust ...
Investor reaction to the deal was muted, with BMO Capital Markets analysts saying they "continue to look for more" from ...
Bristol Myers Squibb has ended the week with an agreement to buy Orbital Therapeutics – a developer of in vivo cell therapies ...
The latest information from the National Intellectual Property Administration shows that Hefei Shanhai Semiconductor Technology Co., Ltd. applied for a patent titled "Battery Management System Fault ...
Key opportunities in the Battery Management System market include growth potential across regions driven by advancements in xEV systems, patent innovation, strategic initiatives from leading suppliers ...
Lee Seokhee, CEO of SK On, has expressed his commitment to expanding the company's technological leadership from electric ...
Japan’s Yokogawa is a global leader in industrial automation and digital transformation, with more than 110 years of ...
The drugmaker has launched an international Phase I trial, dubbed Breakfree-2, in seven countries to test the autologous therapy.
Market opportunities lie in the shift to distributed BMS architectures, offering enhanced reliability and precise data handling for new energy vehicles. Integration of BMS, BDU, and other components ...
Pickering Interfaces, supplier of modular signal switching and simulation solutions, has announced a new addition to its PXI ...
Pharmaceutical Technology on MSN

BMS expands CAR-T portfolio with $1.5bn Orbital buyout

BMS, which already has two FDA-approved CAR T-cell therapies, is eyeing entry into the growing in vivo market.